Resources from the same session
Impact of single heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma
Presenter: Kazuaki Harada, Japan
Session: Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Resources:
Slides
Discussant: SO-29, SO-30
Presenter: Harpreet Wasan, United Kingdom
Session: Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Resources:
Slides
Cardiac Toxicities
Presenter: Pia Osterlund, Finland
Session: Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Resources:
Slides